InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Imiquimod (R837) | Inflammasome-induced extracellular vesicles harbour distinct RNA signatures a... | 2021 | J Extracell Vesicles | Budden C.F. et al. | DOI: 10.1002/jev2.12127 |
| Alhydrogel® adjuvant 2% | Development of a novel ZIKV vaccine comprised of immunodominant CD4+ and CD8+... | 2021 | Vaccine | Sun J. et al. | OI: 10.1016/j.vaccine.2021.07.036 |
| Alhydrogel® adjuvant 2% | Development of combination adjuvant for efficient T cell and antibody respons... | 2021 | PLoS One. | Haseda Y. et al. | DOI: 10.1371/journal.pone.0254628 |
| Adju-Phos® adjuvant | Development of combination adjuvant for efficient T cell and antibody respons... | 2021 | PLoS One. | Haseda Y. et al. | DOI: 10.1371/journal.pone.0254628 |
| Poly(I:C) LMW | Exocyst protein subnetworks integrate Hippo and mTOR signaling to promote vir... | 2021 | Cell Rep. | Zaman A. et al. | DOI: 10.1016/j.celrep.2021.109491 |
| EIF2AK2 | Exocyst protein subnetworks integrate Hippo and mTOR signaling to promote vir... | 2021 | Cell Rep. | Zaman A. et al. | DOI: 10.1016/j.celrep.2021.109491 |
| TLR-Related Dominant Negative Genes | Exocyst protein subnetworks integrate Hippo and mTOR signaling to promote vir... | 2021 | Cell Rep. | Zaman A. et al. | DOI: 10.1016/j.celrep.2021.109491 |
| J774-Dual™ Cells | High potency STING agonists engage unique myeloid pathways to reverse pancrea... | 2021 | J Immunother Cancer. | Ager C.R. et al. | DOI: 10.1136/jitc-2021-003246 |
| THP1-Dual™ Cells | High potency STING agonists engage unique myeloid pathways to reverse pancrea... | 2021 | J Immunother Cancer. | Ager C.R. et al. | DOI: 10.1136/jitc-2021-003246 |
| AddaVax™ | Antigenic and immunogenic evaluation of permutations of soluble hepatitis C v... | 2021 | PLoS One. | Prentoe J. et al. | DOI: 10.1371/journal.pone.0255336 |
| IFA | Antigenic and immunogenic evaluation of permutations of soluble hepatitis C v... | 2021 | PLoS One. | Prentoe J. et al. | DOI: 10.1371/journal.pone.0255336 |
| Poly(I:C) HMW | FIP200 restricts RNA virus infection by facilitating RIG-I activation. | 2021 | Commun Biol. | Wang L. et al. | DOI: 10.1038/s42003-021-02450-1 |
| Poly(dG:dC) | FIP200 restricts RNA virus infection by facilitating RIG-I activation. | 2021 | Commun Biol. | Wang L. et al. | DOI: 10.1038/s42003-021-02450-1 |
| Poly(A:U) | FIP200 restricts RNA virus infection by facilitating RIG-I activation. | 2021 | Commun Biol. | Wang L. et al. | DOI: 10.1038/s42003-021-02450-1 |
| Poly(I:C) LMW | FIP200 restricts RNA virus infection by facilitating RIG-I activation. | 2021 | Commun Biol. | Wang L. et al. | DOI: 10.1038/s42003-021-02450-1 |
| Poly(dA:dT) | FIP200 restricts RNA virus infection by facilitating RIG-I activation. | 2021 | Commun Biol. | Wang L. et al. | DOI: 10.1038/s42003-021-02450-1 |
| 5'ppp-dsRNA | FIP200 restricts RNA virus infection by facilitating RIG-I activation. | 2021 | Commun Biol. | Wang L. et al. | DOI: 10.1038/s42003-021-02450-1 |
| LPS-B5 (LPS from E. coli 055:B5) | FIP200 restricts RNA virus infection by facilitating RIG-I activation. | 2021 | Commun Biol. | Wang L. et al. | DOI: 10.1038/s42003-021-02450-1 |
| R848 (Resiquimod) | Effective Cytotoxicity of Dendritic Cells against Established T Cell Lymphoma... | 2021 | J Immunol. | Dubois S. et al. | DOI: 10.4049/jimmunol.2001123 |
| ODN 1585 - TLR9 ligand | Effective Cytotoxicity of Dendritic Cells against Established T Cell Lymphoma... | 2021 | J Immunol. | Dubois S. et al. | DOI: 10.4049/jimmunol.2001123 |